Sharapova suspension leaves her sponsors in a quandary

On Wednesday, the International Tennis Federation announced that it was suspending Sharapova for two years for taking the performance-enhancing drug meldonium .

The New York Times explained:

After a hearing May 18 and 19, a three-member tribunal appointed by the I.T.F. ruled that while Sharapova’s doping violation was not intentional, “she does bear sole responsibility for the contravention, and very significant fault, in failing to take any steps to check whether the continued use of this medicine was permissible.”